| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |